A shared molecular weakness in glioblastoma tumor cells may offer a new treatment target

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

Researchers at the Icahn School of Medicine at Mount Sinai have identified a shared molecular trait in glioblastoma, an aggressive brain cancer in adults. It resembles one used by immature cells during brain development and may reveal a target for future treatments.

Read original article on Medical Xpress - latest medical and health news stories →